The pharmaceutical industry spends an enormous amount on the development of new drugs with approximately only one out of every 1000 compounds becoming an approved drug. Recent estimates state the average development time is 10 years at a cost $US 1.2 billion. A substantial portion of these dollars is spent in pre-clinical studies testing the compounds' safety and efficacy in small animals and primates.

Major pharmaceutical companies are investing in imaging technology development and in animal imaging centers. Their goal is to accelerate the discovery and approval of drugs. They use animals to analyze drug efficacy, disease progression and drug localization/effects.

• Translational medicine in humans and animals.
• High resolution diagnosis for small animal work.
• 3D imaging for structural and quantitative analysis.
• Replace CT and MR studies and provide an imaging alternative in other multi-modality studies.

Note:
Flash Ultrasound™ is an Investigational Device. It is not currently available for sale. Confirmation of safety and effectiveness is yet to be determined.